Anavex Life Sciences Corp (AVXL)

[Investor2014]

Be careful on the Rett results we have.

Those two adult studies were too small with too much placebo response based on too volatile (in genreal up to 300% between samplings) subjective endpoint scoring methods.

We need Excellence data to tell us which way things point, imo.